Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) A Agarwal, A Mukherjee, G Kumar, P Chatterjee, T Bhatnagar, P Malhotra bmj 371, 2020 | 804 | 2020 |
SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India S Cherian, V Potdar, S Jadhav, P Yadav, N Gupta, M Das, P Rakshit, ... Microorganisms 9 (7), 1542, 2021 | 493 | 2021 |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial R Ella, KM Vadrevu, H Jogdand, S Prasad, S Reddy, V Sarangi, ... The Lancet Infectious Diseases 21 (5), 637-646, 2021 | 455 | 2021 |
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a … R Ella, S Reddy, H Jogdand, V Sarangi, B Ganneru, S Prasad, D Das, ... The Lancet Infectious Diseases 21 (7), 950-961, 2021 | 360 | 2021 |
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial R Ella, S Reddy, W Blackwelder, V Potdar, P Yadav, V Sarangi, VK Aileni, ... The Lancet 398 (10317), 2173-2184, 2021 | 356 | 2021 |
Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India S Cherian, V Potdar, S Jadhav, P Yadav, N Gupta, M Das, S Das, ... BioRxiv, 2021.04. 22.440932, 2021 | 320 | 2021 |
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India MS Dhar, R Marwal, R Vs, K Ponnusamy, B Jolly, RC Bhoyar, V Sardana, ... Science 374 (6570), 995-999, 2021 | 306 | 2021 |
Neutralization of variant under investigation B. 1.617. 1 with sera of BBV152 vaccinees PD Yadav, GN Sapkal, P Abraham, R Ella, G Deshpande, DY Patil, ... Clinical Infectious Diseases 74 (2), 366-368, 2022 | 268 | 2022 |
Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease J Ramachandran, CE Eapen, G Kang, P Abraham, DDJ Hubert, G Kurian, ... Journal of gastroenterology and hepatology 19 (2), 134-138, 2004 | 186 | 2004 |
Full-genome sequences of the first two SARS-CoV-2 viruses from India PD Yadav, VA Potdar, ML Choudhary, DA Nyayanit, M Agrawal, ... Indian Journal of Medical Research 151 (2-3), 200-209, 2020 | 177 | 2020 |
Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B. 1.1. 7 variant of SARS-CoV-2 GN Sapkal, PD Yadav, R Ella, GR Deshpande, RR Sahay, N Gupta, ... Journal of Travel Medicine 28 (4), taab051, 2021 | 146 | 2021 |
Transmission electron microscopy imaging of SARS-CoV-2 S Prasad, V Potdar, S Cherian, P Abraham, A Basu, ICMR Covid Team Indian Journal of Medical Research 151 (2-3), 241-243, 2020 | 131 | 2020 |
Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin PD Yadav, GN Sapkal, R Ella, RR Sahay, DA Nyayanit, DY Patil, ... Journal of Travel Medicine 28 (7), taab104, 2021 | 102 | 2021 |
Is dengue emerging as a major public health problem TS Vijayakumar, S Chandy, N Sathish, M Abraham, P Abraham, ... Indian J Med Res 121 (2), 100-7, 2005 | 99 | 2005 |
Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques PD Yadav, R Ella, S Kumar, DR Patil, S Mohandas, AM Shete, ... Nature communications 12 (1), 1386, 2021 | 95 | 2021 |
HPV DNA in plasma of patients with cervical carcinoma N Sathish, P Abraham, A Peedicayil, G Sridharan, S John, RV Shaji, ... Journal of clinical virology 31 (3), 204-209, 2004 | 91 | 2004 |
Clinical characterization and genomic analysis of samples from COVID-19 breakthrough infections during the second wave among the various states of India N Gupta, H Kaur, PD Yadav, L Mukhopadhyay, RR Sahay, A Kumar, ... Viruses 13 (9), 1782, 2021 | 85 | 2021 |
Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in southern India P Vivekanandan, P Abraham, G Sridharan, G Chandy, D Daniel, ... Clinical infectious diseases 38 (9), e81-e86, 2004 | 83 | 2004 |
First isolation of SARS-CoV-2 from clinical samples in India P Sarkale, S Patil, PD Yadav, DA Nyayanit, G Sapkal, S Baradkar, ... Indian Journal of Medical Research 151 (2-3), 244-250, 2020 | 79 | 2020 |
Distribution of the different genotypes of HCV among patients attending a tertiary care hospital in south India S Raghuraman, RV Shaji, G Sridharan, S Radhakrishnan, G Chandy, ... Journal of clinical virology 26 (1), 61-69, 2003 | 79 | 2003 |